Vaccine against Mycoplasma PRRSV
AssigneeIntervet International B.V.
InventorsChrista Sibilla Drexler, Maarten Witvliet
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an immunogenic dose of immunogenic material of Mycoplasma hyopneumoniae and an immunogenic dose of live attenuated PRRS virus for the manufacture of a vaccine, and to a vaccine kit comprising such a vaccine.
Claims4
A method for the vaccination of pigs against infection with Porcine Reproductive Respiratory Syndrome (PRRS) virus and Mycoplasma hyopneumoniae, said method comprising the steps of administering first a priming vaccination with a vaccine comprising immunogenic material of Mycoplasma hyopneumoniae, followed by combined vaccination with a vaccine comprising immunogenic material of Mycoplasma hyopneumoniae and a live attenuated PRRS virus, wherein said priming vaccination is with a vaccine that contains no live PRRS virus.
Dependencies are inferred from the claim text.